- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 217/24 - Oxygen atoms
Patent holdings for IPC class C07D 217/24
Total number of patents in this class: 472
10-year publication summary
|
31
|
35
|
35
|
39
|
32
|
43
|
39
|
23
|
32
|
6
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Aerie Pharmaceuticals, Inc. | 131 |
24 |
| Celgene Quanticel Research, Inc. | 167 |
19 |
| Bristol-myers Squibb Company | 5080 |
17 |
| FibroGen, Inc. | 186 |
13 |
| Novartis AG | 11238 |
11 |
| Boehringer Ingelheim International GmbH | 4629 |
9 |
| Allergan, Inc. | 2600 |
9 |
| sanofi-aventis | 427 |
9 |
| Pfizer Inc. | 3322 |
8 |
| Resverlogix Corp. | 64 |
7 |
| Genentech, Inc. | 3742 |
6 |
| AstraZeneca AB | 3042 |
6 |
| NHWA Pharma. Corporation | 52 |
6 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 157 |
6 |
| The University of Queensland | 666 |
6 |
| Arbutus Biopharma Corporation | 183 |
5 |
| BELLUS Health Inc. | 19 |
5 |
| Cytokinetics, Inc. | 259 |
5 |
| Nerviano Medical Sciences S.r.l. | 256 |
5 |
| Merck Patent GmbH | 5909 |
4 |
| Other owners | 292 |